Orion
Muriel Joubert is an experienced professional in the field of medicinal chemistry with a focus on drug discovery and project management. Currently serving as the Chemistry Lead for Hit Finding Strategy at Orion Corporation since December 2015, Muriel plays a pivotal role in pain and oncology therapy areas. Prior to this, Muriel held positions as a Research Project Leader and Senior Scientist within Orion, leading various discovery projects in neurological disorders and medicinal chemistry. Muriel’s career includes significant roles at Prestwick Chemical SAS, where project leadership in medicinal chemistry was a key focus, and academic experience as a postdoctoral fellow at Université Louis Pasteur and Emory University. Muriel holds an engineering degree in chemistry from ENSCMu and a PhD in organic chemistry from Université de Haute-Alsace Mulhouse-Colmar.
This person is not in any teams
This person is not in any offices
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.